Next Generation Partners

Firms To Watch: Healthcare and life sciences

Led by Einat Katzenell, Ran Dimant, and Neil Stowe, the Herzliya-based practice at Katzenell Dimant assists tech transfer organisations, investors into the sector, and medical device companies with a broad range of transactional and regulatory issues.

Healthcare and life sciences in Israel

Arnon, Tadmor-Levy

The ‘professional, experienced, talented and dedicated’ team at Arnon, Tadmor-Levy maintains its stellar reputation for handling the full gamut of issues across the sector, including matters concerning the secondary use of health data collaborations, material transfer arrangements, and manufacturing agreements. In Jerusalem, Barry Levenfeld regularly acts for both domestic and international life sciences companies in M&A, private equity, and licensing transactions; the ‘tremendous’ Daniel Green’s primary areas of focus are technology and licensing transactions within the medical device, pharma, and IT industries; and the ‘amazing’ Yoheved Novogroder Shoshan is well-versed in IP law, assisting global pharma entities and investors on in-licensing and R&D collaborations. Working out of the Tel Aviv office, Efrat Shapira-Orren is known for her exceptional experience in assisting private hospitals and medical centers on an array of regulatory issues. Miriam Friedmann is noted for deep expertise in licensing and privacy issues.

Other key lawyers:

Barry Levenfeld; Daniel Green; Efrat Shapira-Orren; Yoheved Novogroder Shoshan; Avi Farchi; Avital Bruker-Yamin; Miriam Friedmann; Arthur Gorelik


‘Excellent and responsive lawyers with deep experience in life sciences. High ethical standards, first-class analysis and practical advice.’

‘Daniel Green is a tremendous life sciences lawyer, who gives strong practical advice.’

‘Avital Bruker Yamini is very professional, fast and pleasant. Also, I find that her thinking is always deep and outside the box, and consulting her gives me a very high added value.’

‘The team’s strength lies with their ability to provide a strong and consistent performance in difficult situations and challenges that lie in our path. The team is thorough, highly trained and qualified in their analysis and assessment of complex issues and concerns that arise. It’s a great privilege to work with such a professional, experienced, talented and dedicated group.’

‘A high-quality, professional and leading office, with excellent legal capabilities and service. Efrat Shapira is an excellent leader.’

‘Efrat Shapira has a lot of experience, with professionalism and knowledge of the complicated and challenging system, with the provision of personal service in complex and sensitive issues.’

‘Understanding the legal aspects of healthcare and life sciences is crucial. It requires not just knowledge of corporate law but also a comprehensive understanding of the therapeutic areas and how innovative technologies impact the legal aspects of this sector. Arnon, Tadmor-Levy team holds this broad experience, quickly identifies the client’s need, and provides professional, prompt, and thorough responses. They also communicate effectively throughout the process.’

‘Yoheved Novogroder Shoshan is an amazing partner. She and her team members are experts at representing me and protecting my interests in the long term. Their legal team is also creative and able to find solutions that work for both sides in a timely manner. The individuals I have worked with have always been communicative, thorough, and quick to respond, which is crucial for our business.’

Key clients

Assuta Medical Centers Ltd. and all subsidiaries

Assuta Ashdod Ltd.

ImmPact Bio

Patho-Lab Diagnostics Ltd.

Incentive Incubator Ltd.

SAREL Supplies & Services for Medicine Ltd.


Skip Therapeutics Ltd.,

Sinusafe Medical Ltd.

Allergan Plc

Stryker Corporation

Super Spectra

Alpha Bio Tec. Ltd.

Endomatic Ltd.

Medison Pharma Group

Heracure Medical

Bio Refine Ltd.

Bioventus LLC

Barclays Capital

Pocared Diagnostics Ltd.

Boston Scientific

Oculis Holding AG (NASDAQ OCS)

FutuRx – The Biotech Accelerator


ALYN Hospital

Sirvir Ltd.

Prilenia Therapeutics

Hubei Forbon Technology Co., Ltd.

Alma Lasers Ltd.

Integra Holdings

Simplificare, Inc.

Oramed Pharmaceuticals

Premia Spine

RMDY Health

On-Sight Medical

Genmab A/S


BioLineRx Ltd.

Hedonia Ltd.

Amylyx Pharmaceuticals



Append Medical

BeWeld Medical


CatchMe Therapeutics

Swift Duct

Work highlights

  • Represented Assuta Medical Centers Ltd. on all legal and regulatory aspects of two incidents of alleged genetic mismatch between a child, who has been conceived through IVF, and one or both of the child’s parents.
  • Assisted the incubator FuturRX (an incubator formed by Orbimed, J&J and Takeda) and its portfolio companies (including ImmPACT Ltd., ImmPACT Inc., MOYA Bio Ltd., RaminoBio Ltd. BSense, and Skip Therapeutics Ltd.) in IP transactions, including representing Skip Therapeutics Ltd. in a collaboration and right to license agreement with Sheba Medical Center relating to Skip’s computational and prioritization platform for splicing manipulation therapies in rare genetic disorders, a collaboration which, due the cutting-edge nature of the technology necessitated an innovative approach.
  • Assisted the MedTech incubator MedXXelerator in multiple funding rounds.


The diverse offering at FISCHER (FBC & Co.) is noted for its ‘vast experience and knowledge' of corporate transactions within the sector, in addition to handling a variety of data protection, corporate governance, and patent portfolio management. Raz Tepper jointly heads the practice alongside Eran Yaniv; Tepper represents both domestic and international biopharmaceutical and medical services clients, and Yaniv is particularly adept at handling cross-border corporate transactions within the medtech space. Shmulik Fried regularly advises funds on their investments into medtech companies within the digital health and medical device industries, and Warren Wienburg, known for his deep knowledge of corporate transactions, was promoted to partner in January 2023. Sharon Gazit and Judy Amidor joined the team from Goldfarb Gross Seligman & Co. in March 2023. Gazit contributes her longstanding expertise in assisting venture capital funds and startups with a broad range of commercial transactions, while Amidor specialists in M&A and licensing agreements within the biotech space.

Practice head(s):

Raz Tepper; Eran Yaniv

Other key lawyers:

Shmulik Fried; Warren Wienburg; Sharon Gazit; Judy Amidor


‘Sharon Gazit is very professional, available and cool-headed.

‘Sharon Gazit is the partner in charge of our business for the past 15 years, with Judy Amidor at her side most if not all this time. Sharon’s practical approach and excellent human skills are highly effective for us in navigating the challenging seas of the start-up environment. Sharon, Judy and their team managed the legal side of several financing rounds, expertly negotiating the legal counsels of our investors with excellent results.’

‘Experienced in life sciences, routine work with investors in the field, deal experience.’

‘Very dedicated and responsive team. Understand urgency and treat such cases in the proper manner. All required solutions were available to us at all times.’

‘The team is very knowledgeable, experienced and has great expertise. Their strength is their vast experience and knowledge.’

Key clients


Kamada Ltd.

Astrazeneca Israel Ltd.


Check Cap Ltd.

Bristol-Meyers Squibb Company

Purple Biotech


OrbiMed Healthcare Fund

OrbiMed Advisors LLC

Rainbow Medical Ltd.

Bluewind Medical Ltd.

Hadassah Medical Organisation

Elgan Pharma

Allmed Solutions

Fisher & Paykel Healthcare Corporation Ltd.

Baring Private Equity Asia (BPEA) EQT

415 Capital Fund II GmbH & Co. KG

Peregrine Ventures Growth Fund

Peregrine Ventures V Fund

Tarom Innovative Technologies Ltd

Starget Pharma

Medici Medical LDT

Lapidot Medical Import & Marketing LTD

Harel Insurance

Pitango Venture Capital

Alpha-Bio Tech Ltd.

Medica Excel Tel Aviv Ltd.

Biotronik se & co.

Allium Medical

American Well Corporation

Meuhedet Health Fund

MetaboMed Ltd.


Motus G.I.

Nano Retina Ltd.


Pangea Therapeutics Ltd.


Truleaf Medical

Allevetix Medical

Metasight Diagnostics



Echo Care

89Bio Ltd


Amicus Therapeutics Inc.

PhaseV Ltd.

LTS Medical Devices Ltd.

Chronisense Medical Ltd

Discure Technologies Ltd.

Stealth Mode Start-up

Baxter International

Eisai Co., Ltd.

IPulse Medical



Ulvera AI

Vitalgo systems Ltd.

Agada Medical Technologies Ltd.



Ayana Pharma Ltd.


Work highlights

  • Represented Perrigo, a Dublin-based over-the-counter drug manufacturer and its Israeli subsidiaries, in commercial and litigation matters.
  • Represented Edwards Lifesciences LLC in several high-profile M&A deals totaling billions of NIS.
  • Providing day-to-day legal counsel to Astrazeneca Israel Ltd. on a variety of matters.

Goldfarb Gross Seligman & Co.

Goldfarb Gross Seligman & Co.‘s broad practice handles a diverse range of matters, including class actions and tender processes. Practice head Hili Cohen maintains a technology focused practice, assisting a range of clients across the medical devices, digital health, and pharma industries with R&D and licensing related transactions, in addition to advising on clinical trials and joint ventures. Ofir Goldstein has exceptional knowledge of technology related licensing agreements, capital financings, and investment agreements on both a domestic and international scale, acting fur numerous start-ups and global life sciences companies. Roy Lieber, Tami Fishman Jutkowitz , Sharon Gazit , and Judy Amidor departed the practice in early 2023.

Practice head(s):

Hili Cohen

Other key lawyers:

Ofir Goldstein; Danny Kleinhendler; Shir Shalev


‘The team works very well together, in a pleasant and professional manner. They demonstrated resilience when dealing with a complex transaction.’

Key clients

3 Millenium Group


Acthera Therapeutics Ltd.

Agada Medical Ltd.



Align Technology, LTD

Almeda Ventures Limited Partnership

American Well

AquafitIntimate Ltd.

ARDiS Ltd.

Arkin Holdings



Best Brain




BioMeat FoodTech



Biotest AG

Bpreven Ltd.

BrainsGate Ltd.


Breath of Life International Ltd. (BOL Group)



Cardiovalve Ltd.

Carestream Health, Inc.

Clal Biotechnologies Industries Ltd.

ClearSkin Ltd.



Covington & Burling

Cronos Group

Curatio Healthcare


Edwards Lifesciences Corporation

eHealth Ventures


Elnis Beauty Ltd


Enveric Biosciences, Inc.

Enzymit Inc.

Eximo Medical Ltd.

GI View Ltd.

Heally Israel LTD.

Hogan Lovells

Human Xtensions Ltd

Igentify Ltd.

Industrie Biomediche Insubri SA


InnoBev Ltd.

InnovaHealth Partners

Inovytec Medical Solutions


Intratech Medical



Itamar Medical Ltd.

Izun Pharma

Keystone Dental Inc.

KTR Medical


Lilach- Live and Die with Dignity

Maccabi Healthcare Services

Madrigal Pharmaceuticals

Magen David Adom In Israel (MDA)

Magenta Medical Ltd.

Mazor Medical Ltd.


MDI Health Technologies.




Mediwound Ltd.


Menorah Insurance Company Ltd.


Morrison & Foerester

Mother’s Choice


My Ukko

Nailomatic Ltd

National Insurance Institute of Israel

NeuroSense Therapeutics

Novo Nordisk A/S

Novolog group

Nuar Technologies Ltd.

Ohhmed Medical Ltd.



Ortho Clinical Diagnostics

Osborne Clark

Outburn Ltd.


Pharmaceutical Research Associates (PRA)

PRA HealthScience.

Premier Research

Providence Health & Services

Q-Art Ltd.

Quest Pharmaceuticals, Inc.

Rafa Laboratories Co. Ltd.

Rainbow Medical Ltd

Rapid Medical Ltd

RealView Imaging Ltd.

Redhill Biopharma Ltd

Regeneron Pharmaceuticals, Inc.

Respiration Scan

ReWalk Robotics Ltd.


Roche Pharmaceuticals (Israel) Ltd.



Sherman Lab

SheRun Labs Ltd.

SHL Telemedicine Ltd.

Sol-Gel Technologies Ltd

Sonivie Ltd

Sonova Holding AG|Sonova Israel Ltd., the Israeli subsidiary of Sonova.|Sonova USA Inc., the American subsidiary of Sonova.

Spatz FGIA


Synergio (Y&B Mother’s Choice Ltd.)

Telesofia Medical Ltd

Temi Global Ltd.

The Board of Directors of Clalit

The Israeli Medical Association

Therapix Biosciences Ltd

Under Pressure

Valcare Medical

Vertex Pharmaceuticals Inc

Vibrant Ltd

VitalGo Systems


Well Beat

WellBeat Ltd

West Pharmaceutical Services, Inc.

Wize Pharma Ltd.

Yissum Research Development

Work highlights

  • Representing pharmaceutical company Rafa Laboratories Co. Ltd. in a motion to certify a class action against it related to the distribution of opioids.
  • Representing Israeli medical device start-up Magenta Medical Ltd. in a 55m USD financing round led by global healthcare investment manager OrbiMed.
  • Advising Magen David Adom In Israel (MDA), Israel’s national prehospital emergency medical services organisation, on dozens of tenders every year, and large scale projects.

Herzog Fox & Neeman

Neta Dorfman-Raviv and Zohar Yahalom jointly lead the ‘efficient, effective, knowledgeable and kind’ team at Herzog Fox & Neeman. The practice displays deep bench strength across a wide variety of areas, advising a varied client base of both state-owned and private hospitals and research institutions on the use of health data and hospital spin-offs. Yahalom is known for his expansive regulatory knowledge, regularly assisting companies in the pharma, biotech, and medical device spaces with reimbursement related matters, and generic competition, and Dorfman-Raviv primarily acts for hospitals, Israeli health maintenance organisations (HMO), and insurers in their interactions with government entities, including the Ministry of Health. Dan Sharot is well-versed in IP licensing issues, regularly advising on medical equipment purchasing, research collaboration, and patent licence agreements.

Practice head(s):

Neta Dorfman-Raviv; Zohar Yahalom

Other key lawyers:

Dan Sharot


‘What sets the office apart is its availability and professionalism. Their strengths are the specific expertise of the team members, so I receive a complete, professional and fast response.’

‘Personal relationship. There is a high level of dedication and work ethic in the office, so I’m sure I’m getting a super professional response.’

‘Herzog’s team is composed of efficient, effective, knowledgeable and kind professionals, who have mastered the industry and stand out from most large firms.’

‘I value their devotion and keen interest to cover the full picture and provide thought to all aspects of the case.’

Key clients



AION Innovations Labs

Alpha Omega

Assuta Ashdod

Assuta Medical Centers

BMC Software

BeeHero Ltd.

Biotic Circular Technologies

Boston Scientific


Clal Insurance Company



Johnson & Johnson

Insurance Agents Association in Israel


Phoenix Insurance Company

Madanes Insurance Agency

Magen David Adom Association in Israel



Merck KGaA

Meuhedet (HMO)




Merck Serono

Eli Lilly Israel

GE HealthCare


Philips Medical and Philips Electronics

Rambam Hospital

Random logic LTD

Sahara Medic

Illumina Inc

Impact Bio (previously named Steba Biotech)

Boehringer Ingelheim Israel



The Israel Museum


Zimmer Biomet

Work highlights

  • Advised the Insurance Agents Association in Israel (in addition to several health insurance insureds) on a petition to be submitted to the Supreme Court of Israel, challenging the latest reform concerning private health insurances held by insureds of HMOs’  additional health care services plan, published in June 2023.

Horn & Co

Horn & Co houses a ‘dedicated and effective’ practice, best known for handling the full spectrum of transactional issues, including asset purchase agreements and joint ventures, in addition to manufacturing, supply, and distribution agreements. Yuval Horn leads the team, and is known for his extensive expertise in handling multijurisdictional M&A, corporate reorganisations, and public offerings in the US, Europe, and Israel. Corporate finance specialist Keren Kanir represents both public and private companies, and investors on a vast array of issues, including the establishment of funds, data licensing agreements, and private investment rounds led by angel investors and venture capital funds.

Practice head(s):

Yuval Horn

Other key lawyers:

Keren Kanir; Yonatan Levinstein; Uri Dotan; Shimrit Roznek


‘Very professional, dedicated and effective.’

Key clients

Biosight Ltd.

Panaxia Pharmaceutical Industries Ltd.

Amorphical Ltd.

Diagnostic Robotics Ltd.

Prisma Photonics Ltd.

Guangzhou Sino-Israel Bio-Industry Investment Fund II (LLP)

Pangea Biomed Ltd.

Vascular Biogenics Ltd.

Immunorizon Ltd.

Work highlights

  • Represented the shareholders of Immunorizon Ltd., a private pharma company, in an acquisition through a share purchase agreement with Purple Biotech Ltd., a clinical-stage company. Immunorizon was purchased for an upfront consideration of $7m, half of which was paid by issuance of shares of the acquirer, which is a dual company traded both in NASDAQ and the Tel-Aviv Stock Exchange. Following the closing, the shareholders of Immunorizon are entitled to receive up to an additional $100m as royalties, milestone payments and exit fees.
  • Advised Vascular Biogenics Ltd., an Israeli company traded on the Nsadaq, on its merger with Notable Labs, Inc., a US private company under which, Notable Labs will merge into a wholly owned subsidiary of VBL, with Notable surviving as a wholly owned subsidiary of VBL.
  • Advised Biosight, an Israeli privately held company, on its entering into an agreement in connection with a reverse triangular merger with Ayala Pharmaceuticals, Inc., a US company traded on OTCQX. Upon completion of the merger, ownership of the combined company will be split, with 55% ownership going to Biosight stockholders and 45% going to Ayala stockholders.

Lipa Meir & Co

Lipa Meir & Co maintains its market-leading reputation for advising cannabis start-ups, whilst handling the full range of contentious and non-contentious issues across the sector. The team regularly acts in class actions and advises on IP licensing issues, fund raisings, and the secondary use of healthcare data. Practice head Gary Copelovitz assists domestic and global healthcare clients with a wide variety of corporate issues and M&A, whilst Meir Elbaum is known for advising public and private hospitals and clinics on healthcare insurance programmes, tenders, and their agreements with importers and suppliers. Dispute resolution expert Isaac Anidjer represents entrepreneurs in procedural matters concerning the acquisition of licenses, and negotiations with healthcare service providers. Anidjer is also noted for his broad knowledge of the operation of geriatric medical centres.

Practice head(s):

Gary Copelovitz

Other key lawyers:

Meir Elbaum; Isaac Anidjer


‘The expertise in the healthcare and technology sectors of the team is unique and hard to find elsewhere.’

‘Gary Copelovitz has lead clients in so many deals that his experience and expertise is unparalleled. He will assist clients navigate the most treacherous waters, and will do it with a smile.’

Key clients

Galil Okek Incubator


Exosomm Ltd.

BlinkAid Ltd.

Regenesis Ltd.

Biopharma Credit PLC

Clalit Health Services

Lahav CRO

L.E.M. Laboratory for Early Detection Ltd.

Mor Institute for Medical Data Ltd.

Mor-Mar Ltd.

Tel Hashomer Hospital

Shila Medical Services Ltd.

Mor Research Applications Ltd.

Medtechnica Orthophone Ltd.

Natural Birth Centre

Tel Bar Industries For Health Institutions Ltd.

Clalit Biomedical Engineering Ltd.

Mileutis Ltd.

Shekel Brainweigh Ltd.

Harel Insurance Company Ltd.

Work highlights

  • Advising a client in a collaboration with a leading science institute to build a research and education venture consisting of multi-omics analyses and repository (biobank) and data-omic based research activities, together with clinical trials, for the development of innovative digital healthcare products and services.
  • Acting for Clalit Health Services on numerous projects and ventures which relate to the secondary use of Clalit health data, and a broad range of commercial, joint ventures and litigation matters. Advised on the implementation of a nationwide arrangement for the shortening of the shifts of residents in State-owned and Clalit-owned hospitals.
  • Advising Schneider Children’s Medical Center of Israel in a collaboration with an internationally renowned AI group in developing an engine based on artificial intelligence, computer vision and machine learning technologies to build products related to child development and child healthcare.

S. Horowitz & Co

Co-led by Tal Band, Dovev Apel, and Ran Vogel, the team at S. Horowitz & Co exhibits deep expertise in the full spectrum of issues concerning product liability cases, IP, and sector specific regulation. The team is noted for handling the patent aspects of corporate transactions, particularly in relation to the financing of innovation focused companies and patent licences. Band is well-versed in the full range of IP issues, including patent, trade mark, and copyright disputes, regularly appearing before the Israeli Patents and Trademarks Office. Apel is particularly adept at handling regulatory issues concerning medical devices, e-health, and pharma, with emphasis on class actions and cases concerning the advertising and distribution of medical products, areas in which Yair Ziv also has a great deal of expertise.

Practice head(s):

Tal Band; Dovev Apel; Ran Vogel

Other key lawyers:

Asaf Renrsler; Moran Katz; Yair Ziv

Key clients

Teva Pharmaceutical Industries Ltd.

Sanofi S.A.

Masimo International SARL

Clever Leaves Holdings, Inc.

Sun Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.

Natera Inc

The Chemical, Pharmaceutical and Environmental Society of the Manufacturer’s Association of Israel

Maccabi Healthcare Services

Procter & Gamble Israel Ltd.

Dexcel Ltd. and Dexcel Pharma Technologies Ltd.

Novocure Inc.

Calsado Ltd. (Clasado Biosciences)

Hadassah Medical Organization

Allergan Inc.

Aleph Farm Ltd.

A.M.I. Medical Technologies Ltd.

Nevia Bio Ltd. (Gina-Life Diagnostics)

Femi Premium Ltd

Forever Living Products (Israel) Ltd.

Seegnal e-health Ltd

Kurt Wolff GmbH & Co. KG

Medial Research Ltd

Yeda Research and Development Ltd.

The Institute for Skin Research

Applied Medical Resources Corporation

Zimmer Biomet

Takeda Pharmaceutical Company

Provention Bio, Inc.

Galmed International Ltd.

Hadasit Medical Research Services and Development Ltd.

American Orthodontics

Simplivia Healthcare Ltd.

Solomon, Levine, and Elstein Ltd.

Tel Aviv University

Euromar Ltd.

Amgen Inc.

Rhenium Research Laboratory Equipment Ltd.

Alpa Cosmetics

K.I. Research Institute (R.A.)

BizTec Entrepreneurship Program

Work highlights

  • Represented Teva Pharmaceutical Industries Ltd. in a motion for preliminary injunction submitted by Novartis AG, regarding Teva’s important launch and subsequent commercial activity in Europe with regards to Fingolimod.
  • Representing Sanofi Aventis SA in a complex motion for certification of a class action suit in the amount of USD 1.5bn, regarding the scope of the information contained in the Consumer Medicine leaflet and summary of product characteristics leaflet.
  • Representing Dexcel and Dexcel Pharma in motions for certification of class actions in connection with an alleged defect in a pharmaceutical preparation, totaling approx. NIS 503m.

Agmon with Tulchinsky Law Firm

Agmon with Tulchinsky Law Firm's diverse offering serves a varied client base of venture capital funds looking to invest in start-ups within the sector, in addition to handling data protection and privacy issues. Ehud Arad, Osnat Sarusi Firstater, and Uri Barak co-lead the practice. Arad’s primary areas of focus include multijurisdictional transactions, having acted for a large number of healthcare start-ups; Firstater leads the firm’s technology practice, primarily advising medtech start-ups on joint ventures and M&A; and Barak is known for his extensive commercial experience, having handled a broad range of series financings and management buyouts. Alon Tabak-Aviram is known for assisting biotech and pharma companies on the negotiation of R&D and manufacturing agreements.

Practice head(s):

Ehud Arad; Osnat Sarusi Firstater; Uri Barak

Other key lawyers:

Alon Tabak-Aviram; Gershon Shalom-Winter; Tamar Nesher; Osnat Sarusi-Firstater; Yifat Tsafrir


‘This is the team I turn to for any work in Israel. Responsive, competent, experienced and good commercial sense.’

‘They have very significant accumulated experience in the healthcare fields, including, but not limited to, licensing, employment law, IP, cyber security and privacy, procurement, investments and other financing and everything else needed by a young and growing company.’

‘Yifat Tsafrir is a great pleasure to work with; she is pleasant, professional and always helps in getting the deal done.’

Key clients

Clalit Healthcare

Livnat Poran


Past and current directors of Teva Pharmaceutical Industries Ltd.

Shaare Zedek Scientific Ltd.

Cantor Fitzgerald

T- Syte

Virtual Care

Hospitech Respiration Ltd.

Lifebiotic Medical research Ltd.

Phebra Pty Ltd

Kaizen Bio-Tech


Reuth Rehabilitation Hospital

Teva Pharmaceutical Industries Ltd.



The National Institute for Biotechnology in the Negev

Ziv Health care


RedHill Biopharma Ltd.

ConTIPI Medical Ltd.

Luneau Technology


Biond Biologics

RA Capital


Work highlights

  • Acting for The National Institute for Biotechnology in the Negev, LTD., a research institute located within Ben-Gurion University, in their licensing, joint ventures, and collaboration activities in Israel and abroad, including with companies in the U.S., Japan, and additional jurisdictions.
  • Representing Teva’s Directors in a motion to certify a derivative action submitted against Teva, it’s officers and a consulting company. The motion concerns the purchase of the Mexican drug company named Rimsa.
  • Advising Betalin, a medical start-up developing an innovative therapy for diabetes treatment that aims to replace insulin therapy for patients, on a Master License Agreement with Yissum Research Development Company, as well as various trial and cooperation agreements with medical institutes internationally, and an investment transaction.

Gornitzky & Co.

Praised by clients for its ‘wide range of expertise', Gornitzky & Co. acts for its varied client base of medical equipment manufacturers and distributors, and pharma companies. The team is jointly led by Assaf Harel, Itamar Mei-Zahav, Netta Shaked-Stadler, and Shy Baranov. Harel is well-versed in the full range of data privacy and cyber-security issues, whilst advising on internal anti-corruption policies. Mei-Zahav is known for his extensive corporate expertise, assisting a number of healthcare clients with IPOS and strategic collaborations. Corporate law specialist Rebecca Genis is particularly adept at handling the drafting of medical data processing agreements within the medical device industry.

Practice head(s):

Assaf Harel; Itamar Mei-Zahav; Netta Shaked-Stadler; Shy Baranov

Other key lawyers:

Ohad Gurfinkel; Rebecca Genis


‘Itamar Mei-Zahav is well-recognised in the industry. He always looks at the big picture.’

‘Excellent partner availability and engagement, personal attention, and availability of lawyers in different fields.’

‘Experts for different topics work together to provide consistent legal advise. Fast and reliable responses.’

‘I have been working with Gornitzky & Co. for several years, and I can confidently say that they are professional and service-oriented lawyers. The wide range of expertise and high quality service is very convenient for the legal counsel needs of companies.’

‘Gornitzky’s attorneys are professionals and provide excellent service.’

Key clients

Siemens Healthcare Ltd.


V-Wave Ltd.

Biomx Inc.

Eitan Medical

Baibys Fertility Ltd.

eHealth Ventures

Sofwave Medical Ltd.


Terem-Emergency Medical Centres

Abbott Medical Laboratories LTD

Qure Ventures

Our Crowd

ILEX Medical Ltd.

Levation Pharma Ltd.

Makesense Digital Health Technologies Ltd.


Aviv Laser Solutions


Work highlights

  • Advising Siemens Healthcare on tenders published by hospitals and HMOs in Israel, commercial agreements, and regulatory privacy matters.
  • Advising Eitan Medical on an asset deal for the sale of a line of business to LTS, a commercial and financing agreement, and privacy matters.
  • Representing Abbott Medical Laboratories LTD in a class action.

Liad Whatstein & Co. Law Office

Rated by clients as ‘one of the top, if not the top' IP firms in Israel, Liad Whatstein & Co. Law Office is well-known for handling the full spectrum of contentious and non-contentious patent-related issues across the life sciences and healthcare sector. The ‘technically excellent, diligent and dedicated' Liad ‎ Whatstein and Amira Mangelus jointly lead the team. Primarily acting for global pharma companies, Whatstein is an IP litigator who has deep knowledge of healthcare regulatory issues and blockbuster drug lifecycle management. Mangelus is an expert in patent litigation, handling infringement actions and patent application prosecutions. Oren Weiner has exceptional expertise in patent term extensions, regularly appearing before the Israeli Patent offices and district courts.

Practice head(s):

Liad Whatstein; Amira Mangelus

Other key lawyers:

Oren Weiner; Gershon Finesilver


‘Liad Whatstein is one of the top, if not the top, patent litigation firms in Israel. The team is very diligent and comes up with creative arguments, which put them head and shoulders above the rest of the firms.’

‘Liad Whatstein is a technically excellent, diligent and dedicated partner who is always available. He is an excellent cross-examiner, and an all round excellent lawyer.’

‘Amira Mangelus has a technical background and has extensive experience with complex cross-border litigations. She is one of the founding partners of the firm, giving pragmatic advice.’

‘Gershon Finesilver is a stand-out patent attorney, with an extensive technical background. His technical knowledge in biological fields excellent and he really understands complex scientific matters.’

Key clients






Bristol Myers








UCB Pharma

Alnylam Pharmaceuticals

H. Lundbeck A/S

Leo Pharma

Novo Nordisk


The State of Israel



The Hebrew University


Dr. Fischer Pharmaceuticals

Harvard University

Immunogen Inc.

Advanced Accelerator Applications


University of Georgia Research Foundation, Inc.

Memo Therapeutics AG

Axcella Health Inc.

Innate PharmaS.A.

Principia Biopharma Inc.

Translate Bio, Inc

Ryvu Therapeutics S.A.

Acceleron Pharma, Inc.

Arbor Biotechnologies, Inc.

Kymab Ltd.

Work highlights

  • Advising major pharmaceutical companies, including Merck & Co., Sanofi, Pfizer, Novartis, BMS, Regeneron, Astellas and Roche on regulatory matters in connection with the local regulatory requirements of the Ministry of Health, including obtaining regulatory approvals for drugs, Data Exclusivity and strategic issues relating to the interplay and linkage between regulatory permits in Israel and worldwide and extension of patent term. The advice relates to blockbuster drugs and is instrumental both in terms of regulatory compliance as well to obtain adequate protection for the massive investments of the companies in pharmaceutical R&D.
  • Representing Sanofi and Regeneron in complex proceedings against Amgen’s patent claiming anti-PCSK9 antibodies. In addition to the complex scientific issues and the experiments submitted by the clients, the matter involves precedential legal issues relating to the scope of antibody patents and whether it is permissible to obtain functional antibody claims.
  • Advising the State of Israel in connection with life science technologies developed in government hospitals and which are service inventions under Israeli law. The work involves licensing technologies to third parties and pursing technologies which have been licensed without the State’s authorization.

M. Firon & Co Advocates and Notaries

M. Firon & Co Advocates and Notaries' ‘multifaceted, attentive and highly experienced' practice handles a broad array of matters, including licensing agreements and investment rounds, investment transactions, and injunction negotiations. Hailed by clients as ‘the most eminent healthcare lawyer in the country', practice co-head Baruch Shugol is known for his deep expertise in the biotech and pharma industries, regularly advising clients on R&D and antitrust issues. The ‘brilliant, conscientious, and reliable' co-head Sivan Narkiss acts for private hospitals, medical device distributors, and biotech start-ups in a vast range of regulatory mandates involving clinical trials and post marketing studies.

Practice head(s):

Baruch Shugol; Sivan Narkiss

Other key lawyers:

Jacob Enoch


‘The team is multifaceted, attentive and highly experienced.’

‘Jacob Enoch is the reason we are at Firon. More than anything we could have possibly expected. Sivan Narkiss is a young and upcoming partner, and Baruch Shugol is truly a seasoned veteran. Top-notch.’

‘We have been using Firon’s fabulous team, exclusively, for well over a decade. Excellent.’

‘Jacob Enoch is very simply the best attorney in Israel, on every level of his very diverse practice.’

‘Baruch Shugol is the most eminent healthcare lawyer in the country. Possesses truly profound knowledge.’

‘Sivan Narkiss is brilliant, conscientious, and reliable.’

‘The team at M. Firon & Co, has guided us through complex clinical trial agreements, ethical and regulatory issues, and matters related to new clinical trials development and approvals. Their knowledge of pharmaceutical regulations and clinical trial issues have proven invaluable. The team stands out for its ability to structure innovative clinical trial protocols and agreements tailored to our specific research needs.’

‘Sivan Narkiss stands out as the go-to partner for our business in general and for our pharmaceutical and clinical trial needs. With over 10 years of experience advising life sciences companies, her knowledge of regulations and relationships with regulatory agencies are unmatched.’

Key clients


Tel Aviv Sourasky Medical Centre

Clalit Health Services

Pharma Israel


EMMS Nazareth Hospital

Hadassah Medical

Herzliya Medical Centre

S.L.H. Medical Services Ltd.

Guangzhou Sino-Israel Bio-industry Venture Capital Investment Fund


Geffen Medical



Pearl Cohen Zedek Latzer Baratz

The broad practice at Pearl Cohen Zedek Latzer Baratz acts for a varied client base of tech transfer companies, healthcare start-ups, and major pharma corporations. All co-heading the practice, Yael Baratz leads on the corporate and licensing side of the practice, handling cross-border M&A and non-dilutive financing issues; Hili Rashkovan regularly assists clients with joint development agreements and clinical trials; and Baruch Avrahami is well-known for advising hospitals and healthcare companies. Dividing their time between Tel Aviv and New York, practice co-head Mark Cohen's primary areas of focus are pharma and medical device related patent prosecutions, and co-head Zeev Pearl is noted for his longstanding expertise in IP portfolio development and licensing disputes.

Practice head(s):

Zeev Pearl; Mark Cohen; Yael Baratz; Hili Rashkovan; Baruch Avrahami

Other key lawyers:

Inbal Perlstein-Mandelbaum; Ephraim Heiliczer; Limor Sandler

Key clients

Bayit Balev

Bayer AG

Rambam Health Care Campus

Pfizer Inc.

Sanofi S.A.

Orgenesis Inc.

Dexcel Pharma

SAREL – Logistics Solutions & Products for Advanced Medicine Ltd.

Maccabi Health Services

Biondvax Pharmaceuticals Ltd.

Ayala Pharmaceuticals

SciVac Ltd.

KAHR Medical Ltd.

Society of Public Hospitals for the Public

Estar Medical


Hillel Yaffe Medical Center

Shamir Medical Center

Poriya Medical Center

Marpai Inc.

Amoon Fund

Nobio Ltd

MerHavim – The Medical Center for the treatment of mental health

Work highlights

  • Representing Bayer (including Bayer Intellectual Property Gmbh, Bayer’s IP arm, and Bayer S.A.S), Sanofi, Pfizer, and Illumina in patent prosecution matters.
  • Advising Orgenesis, a global service provider in the regenerative medicine industry, and its subsidiaries in Israel, Belgium and Korea, on M&A commercial, corporate and IP issues.
  • Representing Israeli hospitals such as Shiba, Rambam, Assaf Harofeh and Hillel Yaffeh, local HMOs such as Maccabi Healthcare, and Sarel, the umbrella organization for procurement of the Israeli hospitals, in commercial, regulatory and litigation matters.

Amit, Pollak, Matalon & Co. Advocates and Notary

The team at Amit, Pollak, Matalon & Co. Advocates and Notary regularly assists with equity investments and data privacy compliance mandates. Practice co-head Ian Rostowsky is particularly adept at handling fund formation and M&A-related issues within the sector, while co-head Yoav Etzyon primarily acts for start-ups and emerging companies within the healthcare and life sciences arena. Assaf Baruch’s main areas of focus are commercial transactions within the tech sector, having advised a number of clients on a variety of commercial transactions, and Stephen Barak Rozen is well-versed in the formation of tech incubators.

Practice head(s):

Ian Rostowsky; Yoav Etzyon

Other key lawyers:

Omer Carmel; Stephen Barak Rozen; Chagit Pedael; Assaf Baruch


‘Very seasoned team, having deep expertise. Provides a wide range of solutions for start-up companies, including finance, Israeli law, employee’s relations, the Israeli Innovation Authority, data security and compliance, and ethics.’

Key clients



Arieli Capital LLC

BT Beamedical Technologies

CanNegev Ltd.

Cell Response Ltd.

Dali Medical Devices Ltd.

Dermafence Ltd.

F.O.R.E Biotherapeutics Ltd.

Galmed Pharmaceuticals Ltd.

Good Energies Ltd.

Healeon Medical Ltd.

Ilumigyn Ltd.

IM Cannabis Corp

KeepMed Ltd.

LionBird L.P


Medcase Health Inc.

Nano-X Imaging Ltd.

New Pace Ltd.

Orsense Ltd.

Polypid Ltd.

Red C Biotech Ltd.

Work highlights

  • Represented F.O.R.E Biotherapeutics in an equity investment transaction and is currently dealing with a merger which will result in the company being flipped from Israel to become a Delaware corporation.
  • Advise Allergan, a manufacturer of medical and cosmetic pharmaceuticals, on aspects of intellectual property, including trademarks, trade secrets and compliance with data privacy protection regulations involved in its business activities.
  • Advising 12.64 Fund on a $20m financing round of Switzerland-based SpacePharma SA, a space-tech startup that is developing miniaturized laboratory systems for use in space.

Barnea Jaffa Lande & Co.

Praised for its ‘very satisfying’ results in a wide variety of matters, including manufacturing and supply agreements, healthcare specific regulatory issues, and tenders, Barnea Jaffa Lande & Co. assists a range of clients, from digital health start-ups, to surrogacy companies. ‘Incredibly smart’ practice head Michael Barnea is noted for his longstanding expertise in advising medical device and healthtech companies, R&D centers, and private equity funds on a vast array of IP and commercial transactions. Ken Shaked regularly assists both public and private corporations with IP due diligence issues, and the drafting and negotiation of technology transfer and licensing agreements.

Practice head(s):

Michael Barnea

Other key lawyers:

Ken Shaked; Ariella Dreyfuss; Ido Freund


‘Barnea covers all the legal structures a high-tech company needs. Over the years, particularly in the past year, they have advised us in various commercial agreements.’

‘Michael Barnea is a true leader; he is incredibly smart and has excellent legal knowledge.’

‘Ken Shaked is responsive and always on top of things.’

‘The team is very professional and wide. We had investment deals, litigations, preparation for IPOs and more. In all of the activities we had, the results were very satisfying. Layers were very responsive, and always supportive.’

Key clients

Manor Medical Group



Maccabi Healthcare

The Enaim Group

Marpe Technologies

Symbiosis C.M

Work highlights

  • Advising Manor Medical Group, a medical provider in Israel in the areas of international surrogacy, egg donation in Israel, and medical tourism to Israel, on commercial matters, including M&A transactions and all required agreements.

Meitar law offices

Jointly led by Haim Gueta, Boaz Mizrahi, and Ron Peleg, the Ramat-Gan based team at Meitar Law Offices is well-equipped to handle the full range of transactional issues, including funding rounds, supply agreements, and investments. Mizrahi is particularly adept at handling licensing deals and collaborations, advising a variety of academic institutes and hospitals. Adi Blumenthal Yaari has a great deal of knowledge surrounding technology and IP, and is well-versed in matters concerning dealings with the Israeli Health Ministry.

Practice head(s):

Haim Gueta; Boaz Mizrahi; Ron Peleg

Other key lawyers:

Daniel Colthof; Adi Blumenthal Yaari


‘All very knowledgeable with high proficiency in the material. The head of the healthcare team is very accessible and attentive to client requests.’

‘Ronnie Peleg is highly accessible and attentive. I specifically appreciate the fact that they lean in to each case.’

‘Ron Peleg is extremely knowledgeable and practical. always available and very responsive and thorough.’

Key clients

Chemomab Therapeutics Ltd. (formerly known as Anchiano Therapeutics Ltd.)

Bionaut Labs Ltd.

Elleos Mental Systems Ltd.

Alive Israel Healthtech Fund L.P.

Neura Inc.

Mapi Pharma Ltd.

Equashield Medical Ltd.

Varay Oncology Systems Ltd.

Accurine Ltd.

PhenoAI Ltd.

GlaxoSmithKline Research & Development Ltd.

Quris Ltd.

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD)

Evogene Ltd.

Sanara Ventures Ltd.

NeoTX Therapeutic Ltd

Hyro AI

Viola Ventures


MediWound Ltd.

Work highlights

  • Represented Bionaut Labs Ltd. in a funding round focused on treatment for malignant glioma brain tumours and Dandy-Walker Syndrome.
  • Represented Innovalve Bio Medical Ltd. In an option agreement to be acquired by a leading pharma company.

Shibolet & Co.

Shibolet & Co.’s varied offering assists a broad client list, consisting of domestic incubators, academic institutions, and investment companies. Ofer Ben-Yehuda leads the team alongside Einat Weidberg. Ben-Yehuda is noted for his expansive transactional expertise, regularly assisting clients with venture capital financings, private placements, and strategic alliances. Weidberg regularly acts for both Israeli and overseas clients in mandates concerning cross-border M&A, public offerings, and corporate debt finance. Regulatory and crisis management specialist Amos Bentzur advises HMOs and both public and private healthcare systems on the full range of operational matters.

Practice head(s):

Ofer Ben-Yehuda; Einat Weidberg

Other key lawyers:

Tal Karplus; Amos Bentzur; Daniel Kariv; Gal Shnaiberg


‘The office is characterised by the pleasant atmosphere of a team that works together for the benefit of the client. The firm employs lawyers who specialise in many fields, and thus provides a broad response, covering all required aspects.’

‘Tal Karplus has vast experience and knowledge in his areas of expertise. Karplus is very pleasant and approachable to his clients and also creates a cooperative working atmosphere with the opposite party.’

Key clients

Biontech SE

Lts Pharmaceutical Solutioms

Jiangsu Aiyimu Medtech Co., Ltd.

Second Skin

Dele Health Tech As

China-Israel Biological Technology Co., Ltd.

Noya Therapeutics Limited

American Ortho


Gilead Sciences Israel

Innovestgenetics Gmbh

Lexington Medical Inc

Pregnantech LTD

Chengdu Kanghong Pharmaceutical Co., Ltd.

OBCTCD 24 Ltd.

Pluristem Ltd.

Nobio Ltd

VUZE medical

CartiHeal (2009) Ltd.

The Trendlines Group Ltd.

Elron Electronic Industries Ltd.

Alon Medtech Ventures Ltd.

BeyeOnics Surgical Ltd.

OrthoSpin Ltd.

NovoCure (Israel) Ltd.

Technion Research and Development Foundation Ltd. and Technion Investment Opportunities Fund

Ancora Medical

ApiFix Ltd.

RDD Pharma Ltd.

Compugen Ltd.

DiA Imaging Analysis Ltd.

Ballet Vision Ltd.

Emulait Inc.

Clalit Health Services

Pi-Cardia Ltd.

Work highlights

  • Represented Dia Imaging Analysis Ltd. in its acquisition by Koninklijke Philips N.V. for up to US$75m. The deal involved adjusting to the acquirer’s procedures while protecting the interests of the client and its securityholders, including publicly traded companies.
  • Advising CartiHeal (2009) Ltd., a technology company, on clinical trials, commercial agreements, and complex strategic transactions. The firm advised the client on a put/call option transaction with Bioventus LLC, which faced funding difficulties, leading to an extensive amendment.
  • Represented Floris Ben Shimon Ltd. and its shareholders in the sale of 100% of their shares to C.T.S. Ltd. for NIS 60M in an all-cash deal. The transaction involved a competitive bidding process, complex negotiations, and discussions with the Israel Competition Authority for regulatory consents.